FEV1 (FORCED EXPIRATORY VOLUME IN THE 1ST SECOND) REVERSIBILITY AFTER NEBULISATION WITH SABA (SHORT ACTING BETA AGONIST) AS A MARKER OF CONTROL OF ASTHMA

Author:

M Anjana.1,K Rugmini.2,P. Verghese Relve.1,k.e elizabeth.3

Affiliation:

1. Junior resident, Dept. Of Paediatrics, Sree Mookambika Institute of Medical Sciences

2. Paediatrician, Taluk Hospital, Fort, Thiruvananthapuram

3. Professor and HOD, Dept. of Paediatrics, Sree Mookambika Institute of Medical Sciences

Abstract

INTRODUCTION: Variable expiratory airow due to bronchoconstriction, airway wall thickening and increased mucus is an obvious feature in asthma. Variable airow obstruction is evidenced by reversibility of FEV1 following a bronchodilator inhalation. PFT (Pulmonary Function Testing) using spirometry is often used for the estimation of FEV1. Reversibility is not uniform in all cases and vary with respect to severity and control of asthma. AIMS & OBJECTIVES: 1) To determine the control of asthma in 5-15-year-old children using GINA checklist and estimate FEV1 before and after SABA nebulisation. 2) To nd out the association between FEV1 reversibility and control of asthma. MATERIALS & METHODS: This cross-sectional study included 90 consecutive 5-15-year-old-children with a clinical diagnosis of asthma attending the Paediatric OPD of a teaching hospital from October-May 2021. The symptoms, signs, comorbidities, treatment, compliance and assessment of control of asthma into 2 subgroups: Well-controlled and Partly-controlled/Uncontrolled asthma, as per GINA 2020 were recorded. All were subjected to spirometry for assessment of FEV1 before and 20 minutes after nebulisation with SABA. Depending upon FEV1, they were grouped as those with >12% reversibility and <12% reversibility. Data analysed using SPSS 20.0, Paired t test for comparison of means, Chi-square test for statistical difference in proportion, and post hoc tests. The RESULTS: M:F ratio was 1.2:1, 52.2% were 10-15 years and 47.8% 5-10 years. 68.9% had partly/uncontrolled, the rest well-controlled asthma (38.1%). The difference between mean FEV1 before (67.9±10.6) and after nebulisation (80.6±9.7) was statistically signicant (p<0.00*). Among those with >12 reversibility, 64.5% were in partly/uncontrolled and 35.5% in well-controlled asthma and the difference was statistically signicant (p -0.013*). The CONCLUSION: nding in the study that 68.9% had partly/uncontrolled asthma is an eye-opener to optimise protocol-based treatment among children. The statistically signicant difference of >12% before and after nebulisation a marker of poor control was observed in 64.5% of partly/uncontrolled asthma compared to 35.5% of well controlled asthma. Hence, the persistence of a signicant degree of bronchodilator response noted in those with partly/uncontrolled asthma is recommended as an objective surrogate of poor asthma control in children who can co-operate for a PFT in order to optimise protocol-based treatment.

Publisher

World Wide Journals

Subject

Law,Cultural Studies,Demography,General Economics, Econometrics and Finance,Political Science and International Relations,Sociology and Political Science,Statistics, Probability and Uncertainty,Economics and Econometrics,Statistics and Probability,Plant Science,Aquatic Science,Economics and Econometrics,Finance,Management, Monitoring, Policy and Law,Ecology,Aquatic Science,Ecology, Evolution, Behavior and Systematics,General Medicine,Economics, Econometrics and Finance (miscellaneous),General Earth and Planetary Sciences,General Environmental Science,General Economics, Econometrics and Finance,Political Science and International Relations,Sociology and Political Science,History,Cultural Studies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3